Select the wavelength according to vessel diameter, depth, and location—not diameter alone. Fine, superficial facial telangiectasias generally respond well to 532 nm systems because the wavelength is strongly absorbed by hemoglobin and targets shallow vessels. Larger or deeper vessels typically require greater penetration, making 940 nm or long-pulsed 1064 nm Nd:YAG more appropriate. Pulse duration, fluence, spot size, cooling, and the vessel’s thermal relaxation time must then be adjusted to complete photocoagulation while protecting the epidermis.
The practical rule is simple: use shorter wavelengths for small, superficial vessels and longer wavelengths for larger or deeper vessels. A multi-wavelength platform is valuable because facial telangiectasias vary substantially by diameter, depth, and anatomical location.
Why Vessel Diameter Changes Wavelength Selection
Smaller vessels need superficial, hemoglobin-selective treatment
Fine capillaries have a small thermal mass and are often located close to the skin surface. 532 nm light is strongly absorbed by oxyhemoglobin, allowing effective heating of these superficial vessels with relatively limited penetration.
This makes 532 nm particularly useful for fine telangiectasias and superficial redness when the target is clearly visible and not deeply embedded in the dermis.
Larger vessels require deeper energy delivery
As vessel diameter increases, more energy must be delivered throughout the vessel wall rather than only to its superficial portion. Longer wavelengths, including 940 nm and 1064 nm, penetrate more deeply and are generally better suited to larger or deeper facial vessels.
The long-pulsed 1064 nm Nd:YAG is especially relevant when vessels are deep, prominent, or poorly treated by superficial wavelengths.
Vessel depth is as important as diameter
A small vessel can still be difficult to treat if it lies deeper in the dermis. Conversely, a relatively larger vessel positioned superficially may be accessible with a shorter wavelength, depending on the device and treatment objective.
Practitioners should therefore assess color, visibility, depth, diameter, and anatomical location before choosing the wavelength.
A Practical Wavelength Framework
532 nm for fine, superficial telangiectasias
Use 532 nm when vessels are:
- Fine and superficial
- Bright red or readily visible
- Located in the superficial dermis
- Present as small linear or branching telangiectasias
The wavelength’s strong hemoglobin absorption supports efficient treatment of small vessels, but its shallower penetration makes it less suitable for deeper or larger structures.
940 nm for intermediate or deeper vascular targets
A 940 nm system can be useful when more penetration is needed than 532 nm can provide, while still targeting vascular chromophores in the red-to-near-infrared range.
Its suitability depends on the specific device, handpiece, pulse structure, cooling system, and clinical indication. It should not be treated as automatically interchangeable with a 1064 nm Nd:YAG system.
1064 nm for large or deeply situated vessels
Long-pulsed 1064 nm Nd:YAG systems are generally selected for:
- Larger-caliber facial vessels
- Deeper vessels
- Prominent vessels on areas such as the nasal ala
- Targets that respond inadequately to superficial wavelengths
The increased penetration comes with a greater requirement for careful parameter selection and epidermal protection.
Match Pulse Duration to Vessel Size
Small vessels require shorter heating times
Small vessels lose heat quickly because of their limited diameter. They generally require shorter pulse durations that correspond to their shorter thermal relaxation times.
Using an excessively long pulse can increase heat diffusion into surrounding tissue and raise the risk of unnecessary epidermal or dermal injury.
Medium vessels need intermediate pulse durations
Medium-sized vessels require more sustained heating to achieve coagulation across the vessel wall. Pulse durations in the millisecond range may be appropriate, depending on the system and target characteristics.
The operator should prioritize the device’s validated treatment protocols rather than selecting a duration from vessel diameter alone.
Large vessels need longer pulses
Larger vessels retain heat for longer and typically require longer pulse durations to heat the full vessel wall uniformly. This is one reason long-pulsed 1064 nm systems are often preferred for larger facial vessels.
However, longer pulses do not eliminate the need for conservative treatment planning. The selected duration must remain compatible with fluence, spot size, cooling, skin type, and the anatomical site.
Adapt the Choice to Facial Anatomy
Nasal ala and dorsum
Vessels around the nasal ala and dorsum may be relatively prominent, curved, or deeper than fine cheek telangiectasias. A longer wavelength may therefore be more appropriate when the vessel does not respond adequately to superficial treatment.
The practitioner must also account for tissue thickness, contour, and the risk of concentrating energy on curved or irregular surfaces.
Cheeks
Cheek telangiectasias often include fine superficial vessels and diffuse erythema. 532 nm, pulsed-dye wavelengths, or IPL-type systems may be appropriate for superficial targets, while deeper or larger vessels may require a longer wavelength.
Diffuse redness should not automatically be treated as if it were a discrete vessel. The treatment objective—spot vessel clearance versus broader erythema reduction—should guide device selection.
Areas with cosmetically important skin
The face has little tolerance for unnecessary thermal injury, particularly in patients prone to pigmentary change or prolonged erythema. Cooling and conservative parameter selection are therefore essential, regardless of wavelength.
Use Cooling and Clinical Endpoints as Safety Controls
Epidermal cooling protects the skin surface
Shorter wavelengths can be strongly absorbed by epidermal melanin, while longer wavelengths can still produce unwanted heat if fluence or pulse duration is excessive. Active or integrated epidermal cooling can help protect the skin and permit safer delivery of therapeutic energy.
Cooling does not compensate for an inappropriate wavelength or excessive settings. It is one part of a complete treatment strategy.
Confirm the response during treatment
Treatment should be guided by the device-specific endpoint and the vessel’s clinical response, such as appropriate vessel blanching or coagulation. Excessive whitening, epidermal injury, blistering, or abnormal pain indicates that treatment should be reassessed.
The endpoint should never be pursued by indiscriminately increasing fluence or repeating pulses over the same area.
Consider skin type and pigmentation risk
Patients with higher epidermal melanin content may have increased risk of burns or post-inflammatory hyperpigmentation, particularly with strongly absorbed shorter wavelengths. Longer wavelengths may offer greater penetration, but they are not risk-free.
A cautious test spot, appropriate cooling, and adherence to the manufacturer’s instructions are important when treating pigment-prone skin.
Understanding the Trade-offs
Shorter wavelengths are efficient but less penetrating
The principal advantage of 532 nm is strong hemoglobin absorption and effective treatment of superficial vessels. Its limitation is shallow penetration and greater potential interaction with epidermal melanin.
It is therefore not the universal choice for every facial telangiectasia.
Longer wavelengths penetrate more deeply but demand more caution
The 940 nm and 1064 nm ranges can reach deeper vascular structures and are better suited to larger vessels. Their deeper energy delivery, however, increases the importance of pulse control, fluence selection, cooling, and anatomical judgment.
A longer wavelength should not be selected solely because a vessel appears large. Depth, skin type, and device characteristics must also be considered.
Multi-wavelength systems improve flexibility, not clinical judgment
A multi-wavelength platform allows the practitioner to treat different vessel populations with more appropriate optical characteristics. It does not automatically improve outcomes if the operator does not correctly identify the target or match pulse duration and energy to the vessel.
The platform should be viewed as a tool for customization rather than a substitute for diagnosis and technique.
Avoid relying on diameter thresholds alone
Published vessel-size categories are useful for conceptual planning, but facial telangiectasias are heterogeneous. A vessel’s apparent diameter may not accurately indicate its depth, blood flow, or thermal behavior.
Exact settings should come from validated device protocols, practitioner training, and real-time clinical endpoints rather than from a diameter chart alone.
How to Apply This to Your Project
Begin by identifying whether the target is fine and superficial, medium-sized, or large and deep, then select the wavelength and pulse structure that match that target.
- If your primary focus is fine, superficial telangiectasias: Start with a hemoglobin-selective superficial option such as 532 nm, using conservative, device-validated parameters and appropriate epidermal cooling.
- If your primary focus is larger or deeper facial vessels: Consider 940 nm or long-pulsed 1064 nm Nd:YAG, with longer pulse durations and careful thermal protection.
- If your primary focus is treating varied facial vessels across multiple locations: Choose a multi-wavelength vascular platform so the wavelength can be adapted to vessel diameter, depth, and anatomy.
- If your primary focus is minimizing adverse effects: Prioritize correct vessel assessment, pulse-duration matching, cooling, test spots where appropriate, and strict adherence to the manufacturer’s protocol.
The safest and most effective wavelength is the one that matches the vessel’s optical and thermal characteristics while preserving the surrounding skin.
Summary Table:
| Vessel Type | Recommended Wavelength | Key Considerations |
|---|---|---|
| Fine, superficial | 532 nm | Strong hemoglobin absorption, shallow penetration; use for bright red, small vessels near the surface. |
| Intermediate/deeper | 940 nm | Deeper penetration than 532 nm; suitable for vessels needing more depth while still targeting vascular chromophores. |
| Large/deep | 1064 nm (long-pulsed) | Deepest penetration; ideal for larger, prominent vessels; require careful parameter selection and cooling. |
Optimize your vascular treatments with BELIS's professional-grade laser systems. Our advanced platforms, including 532 nm, 940 nm, and 1064 nm wavelengths, are designed for clinics and premium salons. Benefit from superior technology, comprehensive training, and reliable support to achieve exceptional patient outcomes. Contact our experts today at Contact Form to elevate your practice.
Related Products
- 9D 7D HIFU Vaginal RF Lifting Treatment
- IPL SHR+Radio frecuency machine
- Professional Face and Vaginal 7D HIFU System for HIFU Clinic Treatments
- 4D Vaginal HIFU and Face HIFU System
- IPL SHR Hair Removal Machine for Permanent Hair Removal
People Also Ask
- Is HIFU treatment considered safe and what are the potential risks? A Guide to Safe Non-Invasive Skin Tightening
- Is a HIFU treatment painful? Discover Comfort Levels and Results for Non-Surgical Lifting
- How does HIFU treatment differ from other skin tightening procedures? Compare Non-Invasive Lifting vs. Surgery
- What are the primary benefits of HIFU treatment? Reveal a Youthful V-Line and Firm Skin Non-Invasively
- Why are HIFU systems equipped with multiple treatment handpieces? Precision Depth Control for Superior Skin Results